one component tmb substrate solution (Elabscience Biotechnology)
Elabscience Biotechnology is a verified supplier 
Elabscience Biotechnology manufactures this product 
94
Structured Review
Elabscience Biotechnology
one component tmb substrate solution
One Component Tmb Substrate Solution, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/components/One-component+TMB+Substrate/pmc13030106-150-2-7
Average 94 stars, based on 20 article reviews
One Component Tmb Substrate Solution, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/components/One-component+TMB+Substrate/pmc13030106-150-2-7
Average 94 stars, based on 20 article reviews
one component tmb substrate solution - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Incubation:Article Title: Designing multifunctional recombinant vaccines: an engineering strategy based on innovative epitope prediction-guided splicing. Article Snippet: .. After incubation, the plate was washed three times with PBS and incubated with HRP-goat anti-mouse IgG (Trans, HS201-01) for 1 h. Following another wash cycle with PBS three times, Article Title: Epidemiological Survey of Porcine Circovirus Types 2 and 3 in Liaoning Region of China and Preparation of Monoclonal Antibodies Against PCV3 Cap Protein. Article Snippet: .. After washing, Article Title: Epidemiological Survey of Porcine Circovirus Types 2 and 3 in Liaoning Region of China and Preparation of Monoclonal Antibodies Against PCV3 Cap Protein Article Snippet: .. After washing, Selection:Article Title: Neutralization of Crimean-Congo hemorrhagic fever pseudotyped virions with heavy chain antibodies. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Neutralization of Crimean-Congo hemorrhagic fever pseudotyped virions with heavy chain antibodies Article Snippet: .. After three rounds of selection, individual colonies were screened by ELISA using HRP-labeled M13 monoclonal antibody (Catalog No. 1973-MM05T-H, Sino Biological, Beijing, China) for detection, with Enzyme-linked Immunosorbent Assay:Article Title: Neutralization of Crimean-Congo hemorrhagic fever pseudotyped virions with heavy chain antibodies. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Article Title: Neutralization of Crimean-Congo hemorrhagic fever pseudotyped virions with heavy chain antibodies Article Snippet: .. After three rounds of selection, individual colonies were screened by ELISA using HRP-labeled M13 monoclonal antibody (Catalog No. 1973-MM05T-H, Sino Biological, Beijing, China) for detection, with other:Article Title: A novel dual-effect bimodal chip cancer research platform: Chips system interconnected vascularized tumor organoids culture with real-time exploration and detection from bench to bedside. Article Snippet: 23 Nowadays, cancer researches widely employed organoids as research model. Organoids 24 provide a realistic applicate scene but how to real-time detect and quantified the organoid 25 status is still a bottleneck.. To bridge this knowledge gap, we developed an all-in-one 26 microfluidic platform that, for the first time, seamlessly integrates a vascularized tumor 27 organoids-on-a-chip model (VOoC) with a real-time ELISA detection module for advanced 28 tumor research and point of care testing (POCT).. The platform features a unique integration 29 of two cutting-edge technologies: (1) VOoC consists of a perfusable self-forming vessel 30 network throughout the tumor organoid, emulates in vivo tumor angiogenesis, and (2) a real31 time microfluidic diagnostic chip equipped with ELISA for simultaneously monitoring of 32 tumor biomarker expression levels. |